Geneva Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-6,830
Closed -$293K 728
2015
Q4
$293K Buy
6,830
+70
+1% +$3.08K 0.01% 508
2015
Q3
$284K Buy
6,760
+27
+0.4% +$1.26K 0.01% 496
2015
Q2
$336K Sell
6,733
-35
-0.5% -$1.66K 0.01% 503
2015
Q1
$305K Sell
6,768
-4,563
-40% -$205K 0.01% 510
2014
Q4
$546K Sell
11,331
-1,281
-10% -$60.9K 0.01% 394
2014
Q3
$604K Buy
12,612
+116
+0.9% +$5.63K 0.01% 390
2014
Q2
$619K Sell
12,496
-199
-2% -$9.31K 0.01% 401
2014
Q1
$597K Buy
12,695
+7,650
+152% +$352K 0.01% 357
2013
Q4
$242K Buy
+5,045
New +$226K ﹤0.01% 436

Other funds holding MET

Geneva Advisors's MET Position: Q1 2016 in Review

Geneva Advisors sold out of MetLife (MET) in Q1 2016, closing a stake of 6,830 shares — an estimated $293K sold.

Geneva Advisors first reported a position in MET in Q4 2013 and held it in 9 quarters. The position peaked at $619K in Q2 2014. 970 funds tracked by Wall St. Rank hold MET as of Q1 2016.

  • Geneva Advisors reported no remaining MetLife position as of Q1 2016 after selling out during the quarter.
  • Geneva Advisors sold 6,830 MetLife shares in Q1 2016, an estimated $293K.
  • Geneva Advisors first reported a position in MetLife in Q4 2013 and held it in 9 quarters.
  • Geneva Advisors's MetLife position peaked at $619K in Q2 2014.
  • 970 funds tracked by Wall St. Rank held MetLife as of Q1 2016.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.